NIH Awards Grant to NuvOx Pharma for Development of Field-ready Syringe for Oxygen Delivery Drug

NCI logo NuvOx Pharma has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS), for development of a novel syringe sonication device that may allow quick preparation of an investigational drug for oxygen delivery. For more information, read here.